Clinical Trial Update: Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab and aldesleukin in metastatic clear cell carcinoma of the kidney has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Carcinoma of Kidney
• Kidney Cancer

Drugs mentioned

• Aldesleukin (interleukin-2)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Jorge A. Garcia, MD | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-08-24